PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10027835-7	1999	The data thus suggest that selective MAO-A inhibitors such as esuprone may be an interesting new approach for the treatment of epilepsy.	esuprone	62-70	monoamine oxidase A	Homo sapiens	37-42	
9174681-0	1997	MAO-A inhibition in brain after dosing with esuprone, moclobemide and placebo in healthy volunteers: in vivo studies with positron emission tomography.	esuprone	44-52	monoamine oxidase A	Homo sapiens	0-5	
9174681-10	1997	Plasma kinetics of esuprone showed a rapid elimination with a half-life of about 4 h. CONCLUSION: The study demonstrates that esuprone was comparable to moclobemide in its effect on MAO-A inhibition in the brain at the doses given.	esuprone	126-134	monoamine oxidase A	Homo sapiens	182-187